Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al

Bente Glintborg; Anne Gitte Loft; Emina Omerovic; Oliver Hendricks; Asta Linauskas; Jakob Espesen; Kamilla Danebod; Dorte Vendelbo Jensen; Henrik Nordin; Emil Barner Dalgaard; Stavros Chrysidis; Salome Kristensen; Johnny Lillelund Raun; Hanne Lindegaard; Natalia Manilo; Susanne Højmark Jakobsen; Inger Marie Jensen Hansen; Dorte Dalsgaard Pedersen; Inge Juul Sørensen; Lis Smedegaard Andersen; Jolanta Grydehøj; Frank Mehnert; Niels Steen Krogh; Merete Lund Hetland

doi:10.1136/annrheumdis-2018-214952

Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al

Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Jakob Espesen, Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, Emil Barner Dalgaard, Stavros Chrysidis, Salome Kristensen, Johnny Lillelund Raun, Hanne Lindegaard, Natalia Manilo, Susanne Højmark Jakobsen, Inger Marie Jensen Hansen, Dorte Dalsgaard Pedersen, Inge Juul Sørensen, Lis Smedegaard AndersenJolanta Grydehøj, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	4
Pages (from-to)	E37-E37
Number of pages	1
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2018-214952
Publication status	Published - 2020

Keywords

Antirheumatic Agents
Biosimilar Pharmaceuticals
Etanercept
Humans
Registries
Treatment Outcome
DMARDs (biologic)
disease activity
outcomes research
anti-TNF

Access to Document

10.1136/annrheumdis-2018-214952

Cite this

Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Pedersen, D. D., Sørensen, I. J., ... Lund Hetland, M. (2020). Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al. Annals of the Rheumatic Diseases, 79(4), E37-E37. https://doi.org/10.1136/annrheumdis-2018-214952

Glintborg, B, Loft, AG, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K , Jensen, DV, Nordin, H, Dalgaard, EB, Chrysidis, S, Kristensen, S, Raun, JL, Lindegaard, H, Manilo, N, Jakobsen, SH, Hansen, IMJ, Pedersen, DD, Sørensen, IJ, Andersen, LS, Grydehøj, J, Mehnert, F, Krogh, NS & Lund Hetland, M 2020, 'Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al', Annals of the Rheumatic Diseases, vol. 79, no. 4, pp. E37-E37. https://doi.org/10.1136/annrheumdis-2018-214952

@article{94a3c1607e2e446a8b52a6b6dc9d219f,

title = "Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al",

keywords = "Antirheumatic Agents, Biosimilar Pharmaceuticals, Etanercept, Humans, Registries, Treatment Outcome, DMARDs (biologic), disease activity, outcomes research, anti-TNF",

author = "Bente Glintborg and Loft, {Anne Gitte} and Emina Omerovic and Oliver Hendricks and Asta Linauskas and Jakob Espesen and Kamilla Danebod and Jensen, {Dorte Vendelbo} and Henrik Nordin and Dalgaard, {Emil Barner} and Stavros Chrysidis and Salome Kristensen and Raun, {Johnny Lillelund} and Hanne Lindegaard and Natalia Manilo and Jakobsen, {Susanne H{\o}jmark} and Hansen, {Inger Marie Jensen} and Pedersen, {Dorte Dalsgaard} and S{\o}rensen, {Inge Juul} and Andersen, {Lis Smedegaard} and Jolanta Grydeh{\o}j and Frank Mehnert and Krogh, {Niels Steen} and {Lund Hetland}, Merete",

note = "COPECARE",

year = "2020",

doi = "10.1136/annrheumdis-2018-214952",

language = "English",

volume = "79",

pages = "E37--E37",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "4",

}

TY - JOUR

T1 - Response to ''To switch or not to switch'

T2 - the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al

AU - Glintborg, Bente

AU - Loft, Anne Gitte

AU - Omerovic, Emina

AU - Hendricks, Oliver

AU - Linauskas, Asta

AU - Espesen, Jakob

AU - Danebod, Kamilla

AU - Jensen, Dorte Vendelbo

AU - Nordin, Henrik

AU - Dalgaard, Emil Barner

AU - Chrysidis, Stavros

AU - Kristensen, Salome

AU - Raun, Johnny Lillelund

AU - Lindegaard, Hanne

AU - Manilo, Natalia

AU - Jakobsen, Susanne Højmark

AU - Hansen, Inger Marie Jensen

AU - Pedersen, Dorte Dalsgaard

AU - Sørensen, Inge Juul

AU - Andersen, Lis Smedegaard

AU - Grydehøj, Jolanta

AU - Mehnert, Frank

AU - Krogh, Niels Steen

AU - Lund Hetland, Merete

N1 - COPECARE

PY - 2020

Y1 - 2020

KW - Antirheumatic Agents

KW - Biosimilar Pharmaceuticals

KW - Etanercept

KW - Humans

KW - Registries

KW - Treatment Outcome

KW - DMARDs (biologic)

KW - disease activity

KW - outcomes research

KW - anti-TNF

U2 - 10.1136/annrheumdis-2018-214952

DO - 10.1136/annrheumdis-2018-214952

M3 - Letter

C2 - 30674476

SN - 0003-4967

VL - 79

SP - E37-E37

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 4

ER -